Gabapentin Solution
Product Images NDC 17856-0600

9 FDA label images from Atlantic Biologicals Corp. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 17856-0600). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Atlantic Biologicals Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

17856 0600 01 Label (2)

17856 0600 01 Label (2)
Gabapentin oral solution 250 mg/5 mL label from Atlantic Biologicals Corp. This prescription drug solution is designed for oral use and delivers 5 mL per dose. Storage instructions indicate refrigeration between 2° to 8°C (36° to 46°F) is required. The label includes a barcode, package and batch details, and a call to reorder at 800.509.7592. Quantity per package is 72 cups.*
FDA Label Image

17856 0600 02 Label (2)

17856 0600 02 Label (2)
Label for Gabapentin oral solution 300 mg/6 mL refrigerated, supplied in 6 mL dosage with a quantity of 72 cups. The label shows storage instructions, GTIN, serial number, expiration date, lot number, and contact information for Atlantic Biologicals Corp., the distributor located in Miami, FL, with the labeler listed as Atlantic Biologicals Corp.*
FDA Label Image

17856 0600 03

17856 0600 03
Label for Gabapentin oral solution 100 mg/2 mL (50 mg/mL) by Atlantic Biologicals Corp. The label indicates the product is delivered in 2 mL volume and includes storage instructions to keep refrigerated at 2°-8°C (36°-46°F) and out of reach of children. The package contains 120 syringes. Additional details include expiration date, lot number, and distributor information for Atlantic Biologicals Corp.*
FDA Label Image

Image Description (Figure 01)

Image Description (Figure 01)
An equation illustrating the formula to calculate Creatinine Clearance (ClCr), which involves age, weight, serum creatinine level, and a factor of 0.85 for female patients. This medical calculation image does not represent the drug product itself.*
FDA Label Image

Image Description (Figure 02)

Image Description (Figure 02)
Chemical structure of gabapentin showing a cyclohexane ring attached to an amino group and an acetic acid group.*
FDA Label Image

Figure 1 (Figure 03)

Figure 1 (Figure 03)
A line graph depicting mean pain score changes over an 8-week period comparing placebo and Gabapentin 3600 mg/day. The x-axis marks weeks from baseline through 8, and the y-axis shows mean pain scores from 0 to 10. The graph indicates a 4-week dose titration period followed by a 4-week fixed dose period.*
FDA Label Image

Figure 2 (Figure 04)

Figure 2 (Figure 04)
A line graph showing mean pain scores over a 7-week period comparing placebo with gabapentin at doses of 1800 mg/day and 2400 mg/day. The X-axis represents weeks from baseline through 7 weeks, including a 3-week dose titration period and a 4-week fixed dose period. The Y-axis shows mean pain scores ranging from 0 to 10. Gabapentin groups show a decrease in mean pain scores over time compared to placebo.*
FDA Label Image

Figure 3 (Figure 05)

Figure 3 (Figure 05)
A bar chart comparing two studies (Study 1 and Study 2) showing percentage values for placebo (PBO) and gabapentin (GBP) at different doses. Study 1 shows PBO at 12% and GBP 3600 at 29%. Study 2 shows PBO at 14%, GBP 1800 at 32%, and GBP 2400 at 34%. Statistical significance markers indicate p-values less than 0.01 and 0.001.*
FDA Label Image

Figure 4 (Figure 06)

Figure 4 (Figure 06)
A scatter plot chart showing percent difference on the vertical axis and daily dose in milligrams (600, 900, 1200, 1800 mg) on the horizontal axis. It compares data points marked as STUDY a, STUDY b, and STUDY c at different daily doses, differentiated by different colored squares, each labeled with letters a, b, or c.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.